Trombonat 50 Tablets — Eltrombopag 50 mg (28 Tabs) Natco
Trombonat 50 mg (Eltrombopag) is an innovative pharmaceutical product that functions as a thrombopoietin (TPO) receptor agonist. It works by stimulating the bone marrow to increase the production of platelets (thrombocytes), the essential blood cells responsible for clotting. This medication effectively reduces the risk of serious bleeding in patients with pathologically low platelet counts.
Manufacturer: Natco Pharma Ltd. (India). 🇮🇳 Produced by one of the world's leading manufacturers of oncology and hematology treatments. The manufacturing facility is fully compliant with international GMP standards, ensuring high purification of the active ingredient and full therapeutic equivalence to the original brand.
Key Features:
- ✅ Direct Stimulation: Activates the body's natural pathways to rapidly raise platelet levels.
- ✅ Injection Alternative: The oral tablet form helps many patients avoid frequent platelet transfusions.
- ✅ Trusted Quality: Natco’s Eltrombopag is widely used in clinical hematology due to its proven bioequivalence.
Prescribed by a hematologist for the treatment of the following conditions:
- 🔹 Immune Thrombocytopenia (ITP): In adults and children when other treatments (such as corticosteroids) have not worked.
- 🔹 Chronic Hepatitis C: To treat thrombocytopenia so that interferon-based antiviral therapy can be administered.
- 🔹 Aplastic Anemia: Severe forms of the disease when immunosuppressive therapy provides an insufficient response.
Sales Unit: Carton box containing 28 tablets (4 blisters of 7 tablets each). Strength: 50 mg per tablet.
⚠️ APPLICATION INSTRUCTIONS:
- Administration: Must be taken on an empty stomach (at least 1 hour before or 2 hours after a meal).
- ✋ Crucial Interaction (Calcium): Eltrombopag binds to calcium and other minerals. **Do not** consume dairy products, antacids, or mineral supplements for at least 2 hours before or 4 hours after taking Trombonat. Failure to follow this may render the medication ineffective.
- Dosage: Strictly individualized based on regular blood tests to reach and maintain safe platelet levels.
- ⛔ Hepatic Impairment: Requires extreme caution and dose adjustments.
- Increased risk of thromboembolism.
- Pregnancy and breastfeeding.
- Hypersensitivity to eltrombopag or any excipients.
Treatment requires regular blood monitoring and liver function tests. Potential side effects include:
- 🟡 Liver: Increased liver enzymes (monitoring of ALT/AST is mandatory).
- 🧠 Nervous System: Headache (very common), insomnia.
- 🤢 Gastrointestinal: Nausea, diarrhea, dry mouth.
- 🦴 General: Muscle pain (myalgia), fatigue.
- 👁️ Vision: Risk of cataract development or worsening (regular eye exams are recommended).
Similar products
What Customers Say
No reviews yet
Your review can be the first!